5Indexed trials
drug · Product Intelligence
Aspirin
Pipeline Intelligence
Aspirin: 5 indexed trials, 5 sponsors; 2 linked Orange Book patents and 13 FDA-linked events where matched.
5Sponsors
2Orange Book patent links
13FDA-linked events
Development evidence
NCT01924325Xijing Hospital · strokePHASE2, PHASE3
NCT03192215Columbia University · strokePHASE3
NCT03356769Peking Union Medical College Hospital · epilepsyPHASE2
NCT03377543Beth Israel Deaconess Medical Center · out_of_scopeEARLY_PHASE1
NCT07617870The First Affiliated Hospital of Zhengzhou University · strokePHASE3
FDA / patent evidence
10646431VAZALORE · app 2036972032-09-29
10786444VAZALORE · app 2036972032-09-29
Regulatory context
FDA_APPROVALVAZALORE · 2021-02-26
FDA_APPROVALASPIRIN AND DIPYRIDAMOLE · 2019-05-24
FDA_APPROVALASPIRIN AND DIPYRIDAMOLE · 2018-08-21
FDA_APPROVALASPIRIN AND DIPYRIDAMOLE · 2017-01-18
FDA_APPROVALASPIRIN AND DIPYRIDAMOLE · 2017-01-18
FDA_APPROVALPRAVIGARD PAC (COPACKAGED) · 2003-06-24
FDA_APPROVALBUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE · 2001-11-30
FDA_APPROVALORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE · 1999-04-30
FDA_APPROVALEXCEDRIN (MIGRAINE RELIEF) · 1998-01-14
FDA_APPROVALPROPOXYPHENE COMPOUND 65 · 1985-03-29
FDA_APPROVALMETHOCARBAMOL AND ASPIRIN · 1982-12-22
FDA_APPROVALPERCODAN ·
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.